How can computers help us get better at cancer screening? Find out more in this blogpost!
Blog
Better Defining Breast Cancer Risk
New research helps to better define #breastcancer risk. Find out more from our RIOT team!
Mapping the Past, Present and Future of Genetics
DNA, once a mystery molecule to scientists, can now be closely studied and even edited to eliminate disease, as discussed in Siddhartha Mukherjee’s recent book, ‘The Gene.’
Using extrachromosomal DNA to understand how cancer cells come in different colours
Not all cancer cells look the same! A research group in Ludwig Institute for Cancer Research has discovered that extrachromosomal DNA can explain how two cancer cells within a tumour are genetically different.These genetic differences may explain why some tumours are more resistant to drug therapy than other tumours. Check out this blog article for more information.
‘Brake’-ing the Cycle
Learn about how scientists are trying to reattach the ‘brakes’ in tumor cells to stop them from continuously dividing.
Pancreatic Cancer … Where do we stand?
November is Pancreatic Cancer Awareness Month. Learn about the efforts scientists are making to improve treatment options for patients affected by this disease.
Playing the Odds: How much can we reduce our risk of getting cancer?
Can we outrun cancer? Scientists debate over how much cancer risk is preventable
Cell specificity: Targeting cancer cells and nothing else
Using viruses to fight cancer? Learn about the history of chemotherapy and a new treatment for Glioblastoma using the Zika Virus!
Power in Pink! New Avenues of Research
The human genome has historically been an enigma to scientists. How much of it is important to cancer? Should we only focus on genes or is there something we’re missing? Here, Dr. Kinjal Desai tells us about ‘non-gene’ regions in the genome that are important to our understanding of breast cancer.
Power in Pink! Tackling challenges of Breast Cancer
Scientists are trying to unravel the complexities of Breast Cancer in order to develop more promising therapies for patients. Learn from Dr. Nathan Schachter, a post-doctoral fellow at SickKids, about his PhD work and what he discovered.
torontoriot.com 